These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 20231550)

  • 1. Summaries for patients. The effects of salsalate on blood sugar control in people with type 2 diabetes.
    Ann Intern Med; 2010 Mar; 152(6):I-40. PubMed ID: 20231550
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial.
    Goldfine AB; Fonseca V; Jablonski KA; Pyle L; Staten MA; Shoelson SE;
    Ann Intern Med; 2010 Mar; 152(6):346-57. PubMed ID: 20231565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summaries for patients. Salsalate for type 2 diabetes mellitus.
    Ann Intern Med; 2013 Jul; 159(1):I-32. PubMed ID: 23817718
    [No Abstract]   [Full Text] [Related]  

  • 4. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 5. Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin.
    Devineni D; Morrow L; Hompesch M; Skee D; Vandebosch A; Murphy J; Ways K; Schwartz S
    Diabetes Obes Metab; 2012 Jun; 14(6):539-45. PubMed ID: 22226086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study.
    Davidson JA; Perez A; Zhang J;
    Diabetes Obes Metab; 2006 Mar; 8(2):164-74. PubMed ID: 16448520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.
    Goldfine AB; Fonseca V; Jablonski KA; Chen YD; Tipton L; Staten MA; Shoelson SE;
    Ann Intern Med; 2013 Jul; 159(1):1-12. PubMed ID: 23817699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
    Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
    Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes.
    Pérez-Monteverde A; Seck T; Xu L; Lee MA; Sisk CM; Williams-Herman DE; Engel SS; Kaufman KD; Goldstein BJ
    Int J Clin Pract; 2011 Sep; 65(9):930-8. PubMed ID: 21849007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes.
    Bahijiri SM; Mira SA; Mufti AM; Ajabnoor MA
    Saudi Med J; 2000 Sep; 21(9):831-7. PubMed ID: 11376359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study comparing the effect of pioglitazone in combination with either metformin or sulphonylureas on lipid profile and glycaemic control in patients with type 2 diabetes (ECLA).
    Karamanos B; Thanopoulou A; Drossinos V; Charalampidou E; Sourmeli S; Archimandritis A;
    Curr Med Res Opin; 2011 Feb; 27(2):303-13. PubMed ID: 21142615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of salicylates in type 2 diabetes.
    Rumore MM; Kim KS
    Ann Pharmacother; 2010; 44(7-8):1207-21. PubMed ID: 20516365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone in a subgroup of patients with type 2 diabetes meeting the criteria for metabolic syndrome.
    Lester JW; Fernandes AW
    Int J Clin Pract; 2005 Feb; 59(2):134-42. PubMed ID: 15854187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of type 2 diabetes. Blood lipids should not be neglected!].
    MMW Fortschr Med; 2000 Nov; 142(44):56. PubMed ID: 11107815
    [No Abstract]   [Full Text] [Related]  

  • 19. Saxagliptin and metformin XR combination therapy provides glycemic control over 24 hours in patients with T2DM inadequately controlled with metformin.
    Stenlöf K; Raz I; Neutel J; Ravichandran S; Berglind N; Chen R
    Curr Med Res Opin; 2010 Oct; 26(10):2355-63. PubMed ID: 20804445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acarbose in therapy of diabetes].
    Mehnert H
    Internist (Berl); 1995 Dec; 36(12):1190-5. PubMed ID: 8567226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.